Seeking Alpha

More on BD fiscal Q2 results

  • Revenues: $2.072B (+3.6%), Medical: $1.116B (+5.1%), Diagnostics: $653M (+0.9%), Biosciences: $302M (+8.2%).
  • EPS: $1.45 (+4.3%).
  • Updated F14 guidance:
  • Revenue growth: 4% - 4.5%.
  • EPS: $6.14 - $6.17, down from $6.19 - $6.22.
  • (BDX)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|